Musculoskeletal involvement in scleroderma

Rheumatic Disease Clinics of North America

Volumn 29, Issue 2, 2003, Pages 391-408

  Pope, Janet E ^a  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTINUCLEAR ANTIBODY; ARTIFICIAL TEAR; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CENTROMERE ANTIBODY; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLCELLULOSE; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PILOCARPINE; RHEUMATOID FACTOR; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ACROOSTEOLYSIS; AMYLOIDOSIS; ANTIBODY DETECTION; ARTHRALGIA; ARTHRITIS; BONE RADIOGRAPHY; BURSITIS; CALCINOSIS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FIBROMYALGIA; FLEXION CONTRACTURE; GOUT; HISTOPATHOLOGY; HUMAN; JOINT BIOPSY; MOUTH HYGIENE; MUSCULOSKELETAL DISEASE; MYOPATHY; MYOSITIS; NERVE COMPRESSION; OSTEOARTHRITIS; OSTEOPOROSIS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCLERODERMA; SJOEGREN SYNDROME; SOFT TISSUE CALCIFICATION; SUBLUXATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0038122869     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(03)00017-6     Document Type: Review

References (74)

1. Misra R, Darton K, Jewkes RF, et al. Arthritis in scleroderma. Br J Rheumatol 1995;34(9):831-7.
2. La Montagna G, Baruffo A, Tirri R, et al. Foot involvement in systemic sclerosis: a longitudinal study of 100 patients. Semin Arthritis Rheum 2002;31(4):248-55.
3. Baron M, Lee P, Keystone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1982;41:147-52.
4. Rodnan GP. The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma): clinical study and pathological examination of synovium in twenty-nine patients. Ann Int Med 1962;56(3):422-39.
5. Ramakrishnan S, Das SK, Mishra K. Systemic sclerosis with pencil-in-cup deformity. Rheumatology (Oxford) 2001;40(5):594-5.
6. Armstrong RD, Gibson T. Scleroderma and erosive polyarthritis: a disease entity? Ann Rheum Dis 1982;41:141-6.
7. Rabinowitz JG, Twersky J, Guttadauria M. Similar bone manifestations of scleroderma and rheumatoid arthritis. Am J Roentgenol Radium Ther Nucl Med 1974;121(1):35-44.
8. Kemp Harper RA, Jackson DC. Progressive systemic sclerosis. Brit J Radiol 1965;38:825-34.
9. Lovell CR, Jayson MIV. Joint involvement in systemic sclerosis. Scand J Rheumatol 1979;8:154-60.
10. Clark JA, Winkelmann RK, McDuffie FC, et al. Synovial tissue changes and rheumatoid factor in scleroderma. Mayo Clin Proc 1971;46:97-103.
11. Kellgren JH, Ball J, Bier F. Clinical significance of the rheumatoid serum factor. Br Med J 1959;29:523-31.
12. Ziff M, Brown P, Lospalluto J, et al. Agglutination and inhibition by serum globulin in the sensitized sheep cell agglutination reaction in rheumatoid arthritis. Am J Med 1956;20:500-9.
13. Baron M, Srolovitz H, Lander P, et al. The coexistence of rheumatoid arthritis and scleroderma: a case report and review of the literature. J Rheumatol 1982;9:947-50.
14. Choen M, Persellin RH. Coexistence of rheumatoid arthritis and systemic sclerosis in four patients. Scand J Rheumatol 1982;11:241-5.
15. Shimomura C, Eguchi K, Mine M, et al. A case of progressive systemic sclerosis accompanied with rheumatoid arthritis. Ryumachi 1989;29:285-90.
16. Yokota E, Matsumoto I, Nakata S, et al. A case of progressive systemic sclerosis associated with rheumatoid arthritis [in Japanese]. Rinsho Ryumachi 1990;3:251-5.
17. Maekawa S, Yano E, Shintani S. A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies [in Japanese]. Ryumachi 1992;32:515-21.
18. Gendi N, Gordon T, Tanner SB, et al. The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 1992;31:783-6.
19. Rozenbaum M, Rosner I. The coexistence of intractable nodular rheumatoid arthritis and scleroderma. Br J Rheumatol 1993;32:82-3.
20. Horiki T, Moriuchi J, Takaya M, et al. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum 1996;39(1):152-6.
21. Zimmermann C, Steiner G, Skriner K, et al. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 1998;41(11):1938-45.
22. Yasunaga S, Higuchi M, Nishizaka H, et al. HLA phenotype and systemic sclerosis-rheumatoid arthritis overlap syndrome: comment on the article by Horiki et al. Arthritis Rheum 1998;41(4):757-8.
23. lwata H, Kinoshita M, Sumiya M, et al. Emergence of erosive polyarthritis coincident with Mycobacterium kansassi pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome. Clin Exp Rheumatol 1999;17(6):757-8.
24. Doran M, Wordsworth P, Bresnihan B, et al. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor. J Rheumatol 2001;28(4):921-2.
25. Schumacher HR. Joint involvement in progressive systemic sclerosis (scleroderma): a light and electron microscope study of synovial membrane and fluid. Am J Clin Pathol 1973;60(5):593-600.
26. Steen VD, Medsger Jr TA. The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997;40(6):1146-51.
27. Rodnan GP, Medsger Jr TA. The rheumatic manifestations of progressive systemic sclerosis (scleroderma). Clin Orthop 1968;57:81-91.
28. Kane-Wanger G, Ostrov B, Freundlich B. Knee contractures as the presenting manifestation of scleroderma. Ann Rheum Dis 1992;51:810-1.
29. Rosenbaum LH, Swartz WM, Rodnan GP, et al. Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism. Arthritis Rheum 1985;28(5):586-9.
30. Herrick A, Rooney B, Finn J, et al. Lack of relationship between functional ability and skin score in patients with systemic sclerosis. J Rheumatol 2001;28:292-5.
31. Clements PJ, Wong WK, Hurwitz EL, et al. Correlates of the disability index of the Health Assessment Questionnaire. Arthritis Rheum 1999;42:2372-80.
32. Ishikawa O, Akimoto S, Sato M, et al. Multiple bursitis in systemic sclerosis. J Rheumatol 1997;24(6):1189-90.
33. Lagana A, Canosi JJ. Subcutaneous bursitis in scleroderma. J Rheumatol 1992;19:1586-90.
34. Englert H, Low S. Pitting oedema in early diffuse systemic scleroderma. Ann Rheum Dis 2001;60(11):1079-80.
35. Tager RE, Tikly M. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in black South Africans. Rheumatology (Oxford) 1999;38(5):397-400.
36. Olsen NJ, King Jr LE, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996;22(4):783-96.
37. Ioannou Y, Sultan S, Isenberg DA. Myositis overlap syndromes. Curr Opin Rheumatol 1999;11(6):468-74.
38. Vazquez-Abad D, Rothfield NF. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 1996;39(2):292-6.
39. Schnitz W, Taylor-Albert E, Targott IN, et al. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. J Rheumatol 1996;23(10):1729-33.
40. Jablonska S, Blaszczyk M. Scleroderma overlap syndromes. Adv Exp Med Biol 1999;455:85-92.
41. Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/Ssa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19(4):403-9.
42. Mok CC, Cheung JC, Yee YK, et al. Unusual overlap of systemic lupus erythematosus and diffuse scleroderma. Clin Exp Rheumatol 2001;19(1):113-4.
43. Bennett RM. Scleroderma overlap syndromes. Rheum Dis Clin North Am 1990;16:185-98.
44. Katano K, Kawano M, Koni I, et al. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001;28:2238-44.
45. Penning CA, Cunningham J, French MAH, et al. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol 1984;58:548-56.
46. Marks RM, Czemiecki M, Andrews BS, et al. The effects of scleroderma serum on human microvascular endothelial cells. Arthritis Rheum 1988;31:1524-34.
47. Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and characterization of circulating antiendothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
48. Renaudineau Y, Grunebaum E, Krause I, et al. Anti-endothelial cell antibodies (AECA) in systemic sclerosis - increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001;33(3):171-9.
49. Hebbar M, Lassalle P, Delneste Y, et al. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome. Ann Rheum Dis 1997;56(4):230-4.
50. Dick T, Mierau R, Bartz-Bazzanella P. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 2002;61:121-7.
51. Labrador M, Alguero A, Diaz C, et al, Antibodies against a novel nucleolar and cytoplasmic antigen (p 105-p42) present in the sera of patients with a subset of rheumatoid arthritis (RA) with signs of scleroderma. Clin Exp Immunol 1998;114(2):301-10.
52. Merkel PA, Polisson RP, Chang Y, et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126(11):866-73.
53. Pope JE, Thompson A. The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 2000;27(6):1450-2.
54. Schoenroth L, Fritzler M, Lonzetti L, et al. Antibodies to β2 glycoprotein I and cardiolipin in SSc. Ann Rheum Dis 2002;61(2):183-4.
55. Pope JE, Thompson A. Mitochondrial autoantibodies to the components of 2-oxoacid dehydrogenase complex are early markers of primary biliary cirrhosis. J Clin Rheumatol 2000;6(2):109-10.
56. Hietaharju A, Jaakelainen S, Kalimo H, et al. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve 1993;16(11):1204-12.
57. Ward M, Cure J, Schabel S, et al. Symptomatic spinal calcinosis in systemic sclerosis (scleroderma). Arthritis Rheum 1997;40(10):1892-5.
58. Durback MA, Schumacher HR. Acute gouty arthritis in four patients with systemic sclerosis. J Rheumatol 1988;15(10):1503-5.
59. Ogiyama Y, Hayashi Y, Kou C, et al. Cutaneous amyloidosis in patients with progressive systemic sclerosis. Cutis 1996;57(1):28-32.
60. Horwitz HM, DiBeneditto Jr JD, Allerga SR, et al. Scleroderma, amyloidosis, and extensor tendon rupture. Arthritis Rheum 1982;25:1141-3.
61. Orihara T, Yanase S, Furuya T. A case of sclerodermatomyositis with cutaneous amyloidosis. Br J Dermatol 1985;112:213-9.
62. Holzman H. Pericollagenous amyloid deposition in the skin and internal organs in scleroderma. Klin Wochenschr 1969;47:390-1.
63. Lowe WC. Scleroderma and amyloidosis. Milit Med 1969;134:1430-3.
64. Ito H, Asao T, Yoshizawa H. A case of progressive systemic sclerosis with systemic amyloidosis and Sjögren's syndrome. Rhumachi 1990;30:198-203.
65. Hamada T, Chanoki M, Hayashi Y, et al. Progressive systemic scleroderma associated with cutaneous amyloidosis. Int J Dermatol 1994;33(9):648-9.
66. Tsuji T, Sawabe M, Kato H, et al. A case of PSS recognized amyloid deposits and newly growing elastic fiber in sclerotic skin. Hifu 1988;30:771-6.
67. La Montagna G, Baruffo A, Abbadessa S, et al. Evidence for bone resorption in systemic sclerosis. J Rheumatol 1995;22:797-9.
68. Di Munno O, Mazzantini M, Massei P, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 1995;14:407-12.
69. da Silva HC, Szejnfeld VL, Assis LS, et al. Study of bone density in systemic scleroderma. Rev Assoc Med Bras 1997;43(1):40-6.
70. Carbone L, Tylavsky F, Wan J, et al. Bone mineral density in scleroderma. Rheumatology (Oxford) 1999;38(4):371-2.
71. Neumann K, Wallace K, Metzger A. Osteoporosis - less than expected in patients with scleroderma? J Rheumatol 2000;27(7):1822-3.
72. La Montagna G, Vatti M, Valenti G, et al. Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 1991;10:18-22.
73. Pope JE, Bellamy N, Seibold JR, et al. A randomized controlled trial of Methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 2001;44:1315-8.
74. Steen VD, Medsger Jr TA. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998;41(9):1613-9.